Silence Therapeutics reported 94.52M in Equity Capital and Reserves for its fiscal quarter ending in September of 2024.


Equity Capital And Reserves Change Date
AstraZeneca USD 44.72B 3.68B Jun/2025
Autolus Therapeutics Ltd 346.46M 24.64M Jun/2025
Hikma Pharmaceutical USD 2.32B 35M Dec/2024
Novartis USD 42.05B 3.6B Jun/2025
Roche Holding CHF 36.16B 3.28B Dec/2024
Silence Therapeutics 94.52M 17.99M Sep/2024